![Drew Sukovich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Drew Sukovich.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Biotechnology | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Drew Sukovich a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
Aspira Biosystems, Inc.
![]() Aspira Biosystems, Inc. Information Technology ServicesTechnology Services Part of Nanomune Technologies, Inc., Aspira Biosystems, Inc. develops technology that enables the capture of targeted proteins. The company is based in San Francisco, CA. The company was founded by Casey Crawford Lynch. Aspira Biosystems was acquired by Nanomune Technologies, Inc. on July 20, 2004. | Information Technology Services | Chief Executive Officer | |
The University of California, San Francisco | College/University | Graduate Degree | |
The University of Nottingham | College/University | Graduate Degree | |
AstraZeneca Pharmaceuticals LP
![]() AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Liverpool John Moores University | College/University | Undergraduate Degree | |
Alzheimers Drug Discovery Foundation
![]() Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Biotechnology | Corporate Officer/Principal | |
AstraZeneca, Inc.
![]() AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
Interplast
![]() Interplast Hospital/Nursing ManagementHealth Services Interplast is a group of individuals founded by Dr. Laub from Stanford University who are concerned with the maldistribution of medicine. Interplast is based in Sunnyvale, CA. The non-profit company provides direct care to people who do not have access to surgery and educate professionals. The group has inspired thousands of international humanitarian trips around the world by many surgeons who are motivated to change lives through plastic and reconstructive surgery. | Hospital/Nursing Management | Director/Board Member | |
Neuroinsights LLC
![]() Neuroinsights LLC Financial ConglomeratesFinance Neuroinsights LLC provides consultation and advice on investing in the neurotech industry. The company was founded by Casey and Zach Lynch and is headquartered in San Francisco, CA. | Financial Conglomerates | Founder | |
Zuckerberg San Francisco General Hospital
![]() Zuckerberg San Francisco General Hospital Hospital/Nursing ManagementHealth Services Zuckerberg San Francisco General Hospital operates hospital. It provides a warm, healing environment with private rooms, abundant natural light, and outdoor gardens. The company was founded in 1915 and is headquartered in San Francisco, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
UCSF School of Medicine | College/University | Corporate Officer/Principal | |
The Ohio State University College of Pharmacy | College/University | Undergraduate Degree | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Neurotechnology Industry Organization | Founder | ||
Boonshoft School of Medicine | College/University | Doctorate Degree | |
LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Sonoma Bioventures | Founder | ||
Lighthouse Pharmaceuticals, Inc.
![]() Lighthouse Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Lighthouse Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that specializes in precision medicine approaches to address major unmet medical needs. The private company is based in San Francisco, CA. The company's expertise lies in small molecule protease inhibition. Lighthouse's lead program, LHP588, is a phase 2b ready orally bioavailable small molecule that targets a specific infectious pathogen, Porphyromonas gingivalis. This pathogen is associated with chronic degenerative and inflammatory disorders such as dementia, periodontal disease, atherosclerosis, and orodigestive cancers. Lighthouse Pharmaceuticals was founded in 2022 by Casey Crawford Lynch, who has been the CEO since 2022. | Miscellaneous Commercial Services | Chief Executive Officer |
Estadísticas
Internacional
Estados Unidos | 20 |
Reino Unido | 3 |
Sectorial
Consumer Services | 8 |
Health Technology | 7 |
Health Services | 3 |
Commercial Services | 3 |
Technology Services | 2 |
Operativa
Corporate Officer/Principal | 9 |
Director/Board Member | 7 |
Founder | 7 |
Undergraduate Degree | 3 |
Chief Executive Officer | 3 |
Las relaciones más conectadas
Insiders | |
---|---|
Casey Lynch | 11 |
Kevin B. Young | 8 |
Stephen S. Dominy | 5 |
- Bolsa de valores
- Insiders
- Drew Sukovich
- Conexiones Empresas